Seb Caille
Senior Director, AOC Process Development Avidity Biosciences, a Novartis Company
Seb Caille, is Senior Director of AOC Process Development at Avidity Biosciences, a Novartis Company, where he leads teams responsible for the development, characterization, and validation of manufacturing processes for late stage AOC programs. He brings deep expertise across CMC development for complex modalities, supporting the advancement of Avidity’s RNA based therapeutics. Prior to Avidity, Seb held scientific leadership roles at Amgen, delivering robust manufacturing processes for small molecules and oligonucleotide based assets across multiple development stages.
Seminars
Wednesday 14th October 2026
Presentation Preview: Assessing Purging Factors for Small Molecule Impurities During Post Conjugation Purification
- Breaking down survey results for solvent and reagent purging in post conjugation UF
- Assessing general guidance for purge factors of small molecule impurities based on survey results
- Putting forward proposals for nominal purging factors for reagents and solvents in regulatory context
